These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 705679)

  • 21. [Effects of cyproterone acetate on cardiovascular risk factors in patients with carcinoma of the prostate (author's transl)].
    Varenhorst E; Karlberg BE; Risberg B; Wallentin L; Wranne B
    Urologe A; 1981 Jul; 20(4):218-22. PubMed ID: 6455834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancer of the prostate. Morbidity and mortality with estrogen therapy].
    Ous S; Fryjordet A; Waaler G
    Tidsskr Nor Laegeforen; 1974 Apr; 94(12):748-51. PubMed ID: 4830337
    [No Abstract]   [Full Text] [Related]  

  • 23. [Current possibilities in the treatment of carcinoma of the prostate gland (author's transl)].
    Tomasović D; Grims P; Bencić K
    Lijec Vjesn; 1976 Apr; 98(4):185-8. PubMed ID: 61554
    [No Abstract]   [Full Text] [Related]  

  • 24. Is there still place for estrogens in the treatment of advanced prostatic carcinoma?
    Steg A
    Prog Clin Biol Res; 1987; 243B():429-34. PubMed ID: 3309995
    [No Abstract]   [Full Text] [Related]  

  • 25. Report of two cases of male breast cancer after prolonged estrogen treatment for prostatic carcinoma.
    Schlappack OK; Braun O; Maier U
    Cancer Detect Prev; 1986; 9(3-4):319-22. PubMed ID: 3017556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hormonodependence and hormonotherapy in cancer of the prostate (author's transl)].
    Juret P; Alperine G
    J Radiol Electrol Med Nucl; 1974 Nov; 55(11):802-4. PubMed ID: 4452960
    [No Abstract]   [Full Text] [Related]  

  • 27. [Regression and disappearance of bone metastasis in a case of prostatic carcinoma after bilateral orchidectomy and oestrogen therapy (author's transl)].
    Suhler A
    J Urol (Paris); 1981; 87(4):227-9. PubMed ID: 7264352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular toxicities of systemic treatments of prostate cancer: oestrogen to the rescue?
    Shah SIA; Wilson HCP; Abel PD
    Nat Rev Urol; 2017 Sep; 14(9):1. PubMed ID: 28786419
    [No Abstract]   [Full Text] [Related]  

  • 29. Cardiovascular toxicities of systemic treatments of prostate cancer: is oestrogen to the rescue?
    Veccia A; Maines F; Caffo O
    Nat Rev Urol; 2017 Sep; 14(9):1. PubMed ID: 28786420
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prostatic cancer, diagnosis and hormonal treatment (author's transl)].
    Rutishauser G
    Schweiz Rundsch Med Prax; 1974 Feb; 63(5):120-3. PubMed ID: 4424280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changes in parameters of the coagulation and fibrinolysis system of the blood in patients with prostate cancer in the framework of estrogen therapy].
    Gembitskiĭ EV; Begunov AB
    Klin Med (Mosk); 1994; 72(2):30-2. PubMed ID: 8015238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Breast irradiation preceding hormone administration in patients with prostatic carcinoma].
    Rupp N; Grünberg G
    Strahlentherapie; 1974 Jul; 148(1):35-8. PubMed ID: 4439429
    [No Abstract]   [Full Text] [Related]  

  • 33. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of advanced oestrogen-resistant prostatic carcinoma with estramustine phosphate.
    Wong AL; McGeorge A; Abel BJ
    Clin Oncol; 1981 Jun; 7(2):163-5. PubMed ID: 7249439
    [No Abstract]   [Full Text] [Related]  

  • 35. [Comparison of histological and cytological studies of the prostate with special reference to oestrogene induced changes (author's transl)].
    Schubert GE; Ziegler H; Völter D
    Verh Dtsch Ges Pathol; 1973; 57():315-8. PubMed ID: 4142204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cardiovascular complications during the estrogen therapy of prostatic cancer patients].
    Gonchar MA; Popov AI
    Urol Nefrol (Mosk); 1985; (2):31-3. PubMed ID: 3992753
    [No Abstract]   [Full Text] [Related]  

  • 37. The choice of estrogen preparations in the treatment of prostatic cancer.
    Morales A; Pujari B
    Can Med Assoc J; 1975 Nov; 113(9):865-7. PubMed ID: 1182631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cancer of the breast in patients having prostatic cancer treated with estrogens. Report of three cases (author's transl)].
    Dore B; Dombriz M; Denis P; Darracq-Paries JC; Barbier J; Aubert J
    J Urol (Paris); 1982; 88(4):247-52. PubMed ID: 7108255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of cytomorphological parameters during hormonal therapy of prostatic carcinoma (author's transl)].
    Keller AJ; Völter D; Bertsch H
    Urologe A; 1981 Jul; 20(4):228-30. PubMed ID: 7196633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cancer of the prostate: estrogen therapy].
    Mauriac L; Richaud P; Mage P; Thomas L; Lamarche P
    Bull Cancer; 1986; 73(1):23-30. PubMed ID: 3779120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.